Authors: MCKAY J RAU R WEISMAN M STEVENS RM ZAUG M VANDERAUWERA P

Citation: J. Mckay et al., A DOUBLE-BLIND, RANDOMIZED, 6-ARM, PARALLEL-GROUP, DOSE-FINDING, DOUBLE-DUMMY, MULTICENTER COMPARISON OF STNFR55-IGG (RO-45-2081-LENERCEPT [LEN]) SUBCUTANEOUS (SC) TO REFERENCE TREATMENT WITH ORAL METHOTREXATE(MTX) AND THEIR COMBINATION IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA) (12-WEEK DOSE-FINDING EFFICACY SAFETY STUDY)/, Arthritis and rheumatism, 41(9), 1998, pp. 595-595

Authors: WEISMAN MH MARKENSON J WIIK A ZAUG M DURRWELL L VANDERAUWERA P STEVENS RM

Citation: Mh. Weisman et al., TNF NEUTRALIZATION DOES NOT CAUSE AUTOANTIBODY CHANGES - THE EXPERIENCE WITH 521 PATIENTS ENROLLED INTO IV RO-45-2081 TRIALS, Arthritis and rheumatism, 40(9), 1997, pp. 304-304

Authors: ZHAO YS SCHIFERL D ZAUG M

Citation: Ys. Zhao et al., RSCU-SOS - A RAPID SEARCHING AND CENTERING UTILITY ROUTINE FOR SINGLE-CRYSTAL X-RAY-DIFFRACTION STUDIES AT SIMULTANEOUS HIGH-PRESSURES AND TEMPERATURES, Journal of applied crystallography, 29, 1996, pp. 71-80

Authors: CUTOLO M KIRKHAM B BOLOGNA C SANY J SCOTT D BROOKS P FORRE O JAIN R KVIEN T MARKENSON J SEIBOLD J STURROCK R VEYS E EDWARDS J ZAUG M DURRWELL L BISSCHOPS C CLAIR PS MILNARIK P BAUDIN M VANDERAUWERA P

Citation: M. Cutolo et al., LOADING MAINTENANCE DOSES APPROACH TO NEUTRALIZATION OF TNF BY LENERCEPT (TNFR55-IGG1, RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED FOR 3 MONTHS - RESULTS OF A DOUBLEBLIND PLACEBO-CONTROLLED PHASE-II TRIAL/, Arthritis and rheumatism, 39(9), 1996, pp. 1294-1294

Authors: NOLTING S REINEL D SEMIG G RECKERSCZASCHKA R BERGSTRAESSER M ZAUG M

Citation: S. Nolting et al., AMOROLFINE SPRAY IN THE TREATMENT OF FOOT MYCOSES (A DOSE-FINDING STUDY), British journal of dermatology, 129(2), 1993, pp. 170-174